A Study on the Efficacy of Atezolizumab Combined with Chemotherapy

Clinical trial NCT06780826 · RECRUITING

Trial details

NCT number: NCT06780826
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Status: RECRUITING
Study type: OBSERVATIONAL

Lung Cancer, Small Cell

Start date: 2024-08-28
Primary completion: 2025-06-30
Enrollment: 1430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.